Anticoagulation and patient cooperation go hand in hand. The journey to 70% TTR – How do we get there?
"High quality anticoagulation management vs new anticoagulants. Why a TTR is important."
Torben Bjerregaard Larsen, MD, Aalborg, Denmark
"Patient compliance, anticoagulants and TTR"
Anders Själander, MD; Sundsvall, Sweden
"Monitoring new oral anticoagulants, managing thrombosis, or both?"
Hugo ten Cate, Maastricht, The Netherlands
"Strategies for a better outcome of the TTR and improved patient compliance"
Round table discussion
Nini Leroul (AKpatient), Torben Bjerregaard Larsen, MD, Denmark; Ulrike Walchshofer (INR-Austria), Benjamin Dieplinger, MD, Austria; Antoîne Gobillard (AVKcontrol), Ludovic Drouet, MD, France; Nicola Merlin (FEDER-AIPA), Gentian Denas, MD, Italy; Andri Färber (INRswiss), Walter Wuillemin, MD, Switzerland; Cees N. de Graaff (STIZAN), Ron van’t Land, MD, The Netherlands; Christian Schaefer (Working group anticoagulated patients), Hannelore Rott, MD, Germany; Luciano Arochena Candame (FEASAN), Angeles Fernandéz, MD, Spain.
